Maine Nurse Practitioner Loses DEA Registration Rights
Published Date: 6/10/2026
Notice
Summary
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
DEA registration revoked for Vermillion
Ashley Vermillion, N.P., had her DEA Certificate of Registration No. MV750134 revoked, so she cannot prescribe, dispense, or otherwise handle controlled substances under her DEA registration. The agency found her Maine nursing license expired on July 8, 2025, and the revocation is effective July 10, 2026.
Pending and future Maine applications denied
The Order also denies any pending applications of Ashley Vermillion, N.P., to renew or modify her DEA registration and denies any other pending application for additional registration in Maine. That denial is issued along with the revocation and is effective July 10, 2026.
Right to seek reconsideration within 15 days
Ashley Vermillion may file a properly supported motion for reconsideration of the factual finding that her Maine nursing license is expired. Any such motion and response must be filed and served by email within fifteen calendar days of the date of this Order.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-15201, Gene M. Koop, D.D.S.; Decision and Order
2026-15199, Kerri Zavota, DVM; Decision and Order
2026-14286, Importer of Controlled Substances Application: Catalent Greenville, Inc.
Catalent Greenville, Inc. wants to become an official importer of some powerful controlled substances, including LSD and related drugs. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 17, 2026. This move could impact how these substances enter the U.S., but no costs or fees are mentioned yet.
2026-14135, David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2026-11571, Notice of Availability of Designation of Chinese Military Companies
The U.S. Department of Defense just named several Chinese companies as military-linked and operating in the U.S. This means these companies, like Qihoo 360 and CH UAV, are officially flagged for their ties to China’s military. The list updates every year through 2030, so businesses and investors should watch out for potential restrictions or impacts on deals involving these companies.
Next: 2026-11573, Certain Smart Devices; Notice of Institution of Investigation
Cerence Operating Company has asked the U.S. International Trade Commission to investigate certain smart devices that might be using their patented technology without permission. This could lead to restrictions on importing and selling these devices in the U.S., possibly affecting companies and shoppers soon. The investigation started on June 5, 2026, and could bring big changes to the smart device market and money flow.